Gonadotropin treatment of hypogonadotropic hypogonadal adolescents

Journal of Pediatric Endocrinology and Metabolism

Volumn 12, Issue SUPPL. 1, 1999, Pages 339-344

  Bouvattier, Claire ^a   Tauber, Maïté ^b   Jouret, Béatrice ^b   Chaussain, Jean Louis ^a   Rochiccioli, Pierre ^b  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b CHU PURPAN   (France)

Author keywords

Gonadotropins; Hypogonadotropic hypogonadism; Puberty; Sperm count

Indexed keywords

CHORIONIC GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; TESTOSTERONE;

ADOLESCENT; ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CRYPTORCHISM; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PHYSICAL DEVELOPMENT; PUBERTY; SEXUAL DEVELOPMENT; SPERMATOGENESIS; SPERMATOZOON COUNT; TESTIS DEVELOPMENT; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME; VIRILIZATION;

ADOLESCENT; ADULT; BODY HEIGHT; CHORIONIC GONADOTROPIN; CRYPTORCHIDISM; DRUG THERAPY, COMBINATION; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; LIBIDO; MALE; MENOTROPINS; PUBERTY; SEXUAL MATURATION; SPERM COUNT; TESTIS; TESTOSTERONE;

EID: 0033039053     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Bhasin S. Androgen treatment in hypogonadal men. Clinical Review 34. J Clin Endocrinol Metab 1992; 74: 1221-1225.
2. Whitcomb RW, Crowley WF. Diagnosis and treatment of isolated gonadotropin-releasing hormone deficiency in men. J Clin Endocrinol Metab 1990; 70: 3-7.
3. Roger M, Chaussain JL, Berlier S, Bost M, Canlorbe P, Colle M, et al. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules. J Clin Endocrinol Metab 1986; 62: 670-677.
4. David G, Bisson JP, Czyglick F, Jouannet P, Gernigon C. Anomalies morphologiques du spermatozoide humain 1. Propositions pour un système de classification. J Gynecol Obstet Biol Reprod 1975; 4: (Suppl 1): 17-36.
5. Kliesch S, Behre HM, Nieschlag E. High efficacy of gonadotropin or pulsatile gonadotropin-releasing hormone treatment in hypogonadotropic hypogonadic men. Eur J Endocrinol 1994; 131: 347-354.
6. Kirk JMW, Savage MO, Grant DB, Bouloux PMG, Besser GM. Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotropic hypogonadism. Clin Endocrinol 1994; 41: 57-64.
7. Ley SB, Leonard JM. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens. J Clin Endocrinol Metab 1985; 61: 746-752.
8. Schaison G, Young J, Pholsena M, Nahoul K, Couzinet B. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1993; 77: 1545-1549.
9. Burris AS, Rodbard HW, Winter SJ, Sherins RJ. Gonadotropin therapy in men with isolated hypogonadotrophic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Clin Endocrinol Metab 1988; 66: 1144-1151.
10. Finkel DM, Phillips JL, Snyder PJ. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med 1985; 313: 651-655.
11. Forest MG, Lecoq A, Saez JM. Kinetics of human chorionic gonadotropin-induced steroidogenic response of the human testis. J Clin Endocrinol Metab 1979; 49: 284-291.
12. Zachmann MA, Prader HP, Kind H, Hafliger H, Budliger H. Testicular volume during adolescence: cross sectional and longitudinal study. Helv Paediatr Acta 1974; 29: 61-64.
13. Spratt DI, Can DB, Merriam GR, Scully RE, Rao PN, Crowley WF. The spectrum of abnormal pattern of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations. J Clin Endocrinol Metab 1987; 64: 283-291.
14. Liu L, Banks SM, Barnes KM, Sherins RJ. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1988; 67: 1140-1145.
15. Hadziselimovic F, Herzog B. Treatment with a luteinizing hormone-releasing hormone analogue after successful orchiopexy markledly improves the chance of fertility later in life. J Urol 1997; 156: 1193-1195.
16. Burges S, Calderon MD. Subcutaneous self administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish collaborative group on male hypogonadotropic hypogonadism. Hum Reprod 1997; 12: 980-986.
17. Saal W, Happ J, Cordes U, Baum RP, Schmidt M. Subcutaneous gonadotropin therapy in male patients with hypogonadotropic hypogonadism. Fertil Steril 1991; 56: 319-324.
18. Clopper RR, Voorhess ML, Macgillivray MH, Lee PA, Mills B. Psychosexual behavior in hypopituitary men: a controlled comparison of gonadotropin and testosterone replacement. Psychoneuroendocrinology 1993; 18: 149-161.